Preterm Birth Clinical Trial
Official title:
Cardiovascular and Cerebrovascular Responses to Cardio-respiratory Events in Very Preterm Infants During the Transitional Period
Intermittent episodes of hypoxemia and/or bradycardia, also defined as cardio-respiratory events (CRE) are very frequent in preterm infants and may result in transient hypoxia and hypoperfusion of target organs, with possible clinical implications. The hemodynamic instability that characterizes the first 72 hours of life, also called as transitional period, place preterm infants at high risk of complications and may contribute to enhance fluctuations in end-organ perfusion and oxygenation induced by CRE. In this study we aimed to explore cardiovascular and cerebrovascular changes determined by different CRE types in preterm infants during the transitional period.
Intermittent episodes of hypoxemia and/or bradycardia, also defined as cardio-respiratory
events (CRE) are very frequent in preterm infants and may result in transient hypoxia and
hypoperfusion of target organs, with possible clinical implications. The hemodynamic
instability that characterizes the first 72 hours of life, also called as transitional
period, place preterm infants at high risk of complications and may contribute to enhance
fluctuations in end-organ perfusion and oxygenation induced by CRE. Moreover, during this
period, several clinical variables (e.g., antenatal steroid administration, gestational age
[GA], patent ductus arteriosus [PDA], respiratory support etc.) may contribute to modulate
the hemodynamic fluctuations in response to CRE.
Hence, this study aims:
- to explore changes in the main cardiovascular and cerebrovascular parameters elicited by
different CRE types
- to evaluate whether different antenatal, perinatal and postnatal factors may influence
the observed cardiovascular and cerebrovascular responses to CRE.
Infants born at S. Orsola-Malpighi Hospital are consecutively enrolled in this observational,
prospective study if fulfilling the following eligibility criteria: gestational age (GA) <32
weeks' gestation, birth weight <1500 g, 0-12 hours of life, written informed consent obtained
from the parents/legal guardians of each infant.
As routinely performed in infants with the eligible characteristics, the enrolled infants
undergo a simultaneous, continuous and non-invasive monitoring of
- peripheral oxygen saturation (SpO2) and heart rate (HR) using a pulse oximeter
- cerebral tissue oxygenation index (cTOI) and cerebral total hemoglobin index (cTHI),
which represents a proxy of cerebral blood flow, using near infrared spectroscopy.
Cerebral fraction of oxygen extraction (cFTOE) is also calculated as follows:
(SpO2-cTOI)/SpO2.
- cardiovascular parameters (cardiac output [CO], stroke volume [SV], cardiac
contractility index [ICON], systemic vascular resistance [SVR]) using electrical
cardiometry.
In the enrolled infants, each monitoring device is connected via a RS232 cable to a laptop
running ICM+® (https://icmplus.neurosurg.cam.ac.uk/, Cambridge Enterprise, UK), a software
tool that allows a real-time synchronized multi-parametric data collection, which recorded
the above mentioned parameters continuously, from the time of enrollment up to 72 hours of
life.
Cardiorespiratory event types are classified on the basis of SpO2 and HR values as follows:
- isolated desaturation (ID): SpO2 <85% and classified into mild (SpO2 80-84%), moderate
(SpO2 70-79%) and severe (SpO2 <70%).
- isolated bradycardia (IB): any HR drop <100 bpm or >30% from baseline values, calculated
daily over the first 72 hours of life
- desaturation and bradycardia occurring within a 60-sec time window: combined events
(DB).
The following antenatal and neonatal data are tracked down on a specific case report form:
GA, antenatal steroids (complete course vs. incomplete course or not given) evidence of
reversed end-diastolic flow at antenatal umbilical Doppler (uREDF) (present vs. absent);
ventilatory status over the first 72 hours of life (continuous positive airway pressure
[CPAP] vs. nasal cannulas or self-ventilating in air [SVIA]); surfactant administration;
development of IVH over the first 72 hours of life.
A screening echocardiogram is routinely performed at the time of enrollment and repeated 6-12
hourly in the presence of a patent ductus arteriosus (PDA) or 12-24 hourly if there is no
evidence of PDA. Based on echocardiographic features, the ductal status is classified as
follows: no evidence of PDA (noPDA), restrictive PDA (rPDA; restrictive shunt pattern and
left atrium to aortic root ratio [LA:Ao] ratio <1.5), hemodynamically significant PDA (hsPDA;
pulsatile shunt pattern, LA:Ao ratio ≥1.5 or presence of reversed end-diastolic flow either
in the descending aorta or in the anterior cerebral artery).
For statistical analysis, percentage changes of cardiovascular (CO, ICON, SVR) and
cerebrovascular (cTOI, cTHI, cFTOE) parameters will be compared between different CRE types
(ID, DB and IB) using Kruskal-Wallis test. Generalized estimating equation (GEE) models will
be used to analyze the concomitant effect of clinical variables (e.g., GA, uREDF, antenatal
steroids, ductal and ventilatory status etc.) on the percentage changes of the study
parameters. IBM SPSS, version 25.0, will be used for statistical analysis. The significance
level is set at p<0.05.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Not yet recruiting |
NCT03418012 -
Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB
|
N/A | |
Not yet recruiting |
NCT03418311 -
Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome
|
N/A | |
Completed |
NCT02993744 -
Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone
|
N/A | |
Active, not recruiting |
NCT02673216 -
Infection and Adverse Pregnancy Outcome
|
||
Completed |
NCT01683565 -
Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood
|
Phase 4 | |
Completed |
NCT01412931 -
Protein and Ultrasound Indicators of Preterm Birth
|
N/A | |
Completed |
NCT01460576 -
Improving Prematurity-Related Respiratory Outcomes at Vanderbilt
|
N/A | |
Completed |
NCT02606058 -
The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?
|
N/A | |
Terminated |
NCT03715530 -
Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women
|
N/A | |
Completed |
NCT00422526 -
Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial
|
Phase 3 | |
Enrolling by invitation |
NCT04251260 -
Effectiveness of Positioning in Preterm Neonates
|
N/A | |
Completed |
NCT03668860 -
India Dexamethasone and Betamethasone
|
Phase 1 | |
Recruiting |
NCT03638037 -
Correlation Between Maternal Vitamin D Level And Preterm Birth
|
||
Completed |
NCT02225353 -
Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery
|
Phase 2 | |
Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
Completed |
NCT03144141 -
Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery
|
N/A | |
Completed |
NCT05210985 -
Examination of the Relationship Between Home Affordances With Development
|
||
Completed |
NCT04811742 -
Effect of Immersion Bathing and Showering Applications on Comfort Level and Physiological Parameters of Newborn
|
N/A |